US2019343902A1PendingUtilityA1

Treatment and Prophylaxis for Neurological Conditions and Diseases

60
Assignee: NUBIOME INCPriority: Feb 20, 2016Filed: Jul 27, 2019Published: Nov 14, 2019
Est. expiryFeb 20, 2036(~9.6 yrs left)· nominal 20-yr term from priority
Inventors:Brian Lue
C12Y 304/21062C12Y 304/24A61K 35/747A61K 38/482A61K 38/4886
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An embodiment is a method of mitigating or treating anxiety that includes administering an effective amount of a medicament comprised of Lactobacillus bulgaricus B-30892 and/or a supernatant resulting from culturing Lactobacillus bulgaricus B-30892 to a human to mitigate or treat anxiety.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of mitigating or treating anxiety comprises:
 administering an effective amount of a medicament comprised of  Lactobacillus bulgaricus  B-30892 and/or a supernatant resulting from culturing  Lactobacillus bulgaricus  B-30892 to a human to mitigate or treat anxiety.   
     
     
         2 . The method of  claim 1  wherein the medicament further comprises oligopeptidase F (PepF). 
     
     
         3 . The method of  claim 1  wherein the medicament further comprises endopeptidase O (PepO). 
     
     
         4 . The method of  claim 1  wherein the medicament further comprises endopeptidase O2 (PepO2). 
     
     
         5 . The method of  claim 1  wherein the medicament further comprises subtilisin. 
     
     
         6 . A method of mitigating or treating anxiety comprises:
 administering an effective amount of a medicament comprised of liquid or dried secretions from  Lactobacillus bulgaricus  B-30892 to a human to mitigate or treat anxiety.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.